Form 4: Pfizer Executive Vice President Douglas Lankler Reports Stock Transactions

Executive Vice President Douglas M. Lankler reports the earn-out and subsequent transactions of stock appreciation rights, including share withholding for tax obligations and exercise price, affecting his beneficial ownership of Pfizer common stock.

Summary

• On February 23, 2024, Douglas M. Lankler, an Executive Vice President at Pfizer Inc., reported transactions involving Pfizer common stock.
• These transactions included the earn-out of 95,755 stock appreciation rights at a price of $27.34.
• Shares were withheld to satisfy tax obligations (6,618 shares at $27.76) and to cover the payment of the exercise price (77,384 shares at $27.37).
• Following these transactions, Lankler directly owns 146,918 shares of common stock and indirectly owns 1,832 shares through a Rule 16b-3 plan.

Sentiment

Score: 5

Explanation: This is a neutral report of stock transactions, with no inherent positive or negative sentiment.

Industry Context

This filing is a routine disclosure of stock transactions by a company executive, as required by the SEC. It provides transparency into the executive's holdings and transactions in the company's stock.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in the executive's holdings, but the overall effect is likely negligible.

Key Dates